Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Hua Medicine (Shanghai) Ltd. (2552.HK)

Compare
2.050
+0.010
+(0.49%)
At close: 4:08:01 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
76,610
76,610
17,599
--
--
Cost of Revenue
39,236
39,236
9,910
--
--
Gross Profit
37,374
37,374
7,689
--
--
Operating Expense
326,466
326,466
248,362
315,180
352,382
Operating Income
-289,092
-289,092
-240,673
-315,180
-352,382
Net Non Operating Interest Income Expense
8,605
8,605
573
1,086
-26
Pretax Income
-211,234
-211,234
-203,507
-325,734
-393,134
Net Income Common Stockholders
-211,234
-211,234
-203,507
-325,734
-393,134
Diluted NI Available to Com Stockholders
-211,234
-211,234
-203,507
-325,734
-393,134
Basic EPS
-0.22
-0.22
-0.21
-0.34
-0.41
Diluted EPS
-0.22
-0.22
-0.21
-0.34
-0.41
Basic Average Shares
977,054.886
977,054.886
966,730.201
957,488.541
950,508.749
Diluted Average Shares
977,054.886
977,054.886
966,730.201
957,488.541
950,508.749
Rent Expense Supplemental
1,071
1,071
767
--
--
Total Expenses
365,702
365,702
258,272
315,180
352,382
Net Income from Continuing & Discontinued Operation
-211,234
-211,234
-203,507
-325,734
-393,134
Normalized Income
-211,234
-211,234
-203,248
-324,467
-394,235
Interest Income
16,512
16,512
4,240
5,036
4,370
Interest Expense
7,907
7,907
3,667
3,950
4,396
Net Interest Income
8,605
8,605
573
1,086
-26
EBIT
-203,327
-203,327
-199,840
-321,784
-388,738
EBITDA
-167,089
-167,089
-168,063
-290,195
-370,290
Reconciled Cost of Revenue
39,236
39,236
9,910
--
--
Reconciled Depreciation
36,238
36,238
31,777
31,589
18,448
Net Income from Continuing Operation Net Minority Interest
-211,234
-211,234
-203,507
-325,734
-393,134
Total Unusual Items Excluding Goodwill
--
--
-259
-1,267
1,101
Total Unusual Items
--
--
-259
-1,267
1,101
Normalized EBITDA
-167,089
-167,089
-167,804
-288,928
-371,391
12/31/2020 - 9/14/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers